KPMG Busting the niche- the future of genomics

The sequencing of patients’ genes has opened the way for exciting new approaches to therapy. The challenge for the pharmaceutical and life sciences sectors is to adapt R&D, production and sales and marketing to become swift, agile developers of more specialised drugs with smaller target audiences